nafamostat has been researched along with Hyponatremia in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimura, H | 1 |
| Yamaya, M | 1 |
1 other study available for nafamostat and Hyponatremia
| Article | Year |
|---|---|
A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus Disease.
Topics: Animals; Antiviral Agents; Benzamidines; Disseminated Intravascular Coagulation; Ebolavirus; Factor | 2015 |